Clinical Trials

15 enrolled 12 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00792077 2021-07-01

A Pilot Study to Investigate the Effect of Cytotoxic Therapy and/or Radiotherapy on Cancer Related Sleep Disturbances in CLL and Breast Cancer Patients Experiencing Fatigue

6 enrolled 10 charts

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01497496 2021-04-27

Ofatumumab/Methylprednisolone and Ofatumumab/Lenalidomide for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

29 enrolled 9 charts

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT02309515 2021-01-19

Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis

12 enrolled 8 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02472691 2020-05-28

AZALENA

MyeloidOther hematologic neoplasm

50 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00632359 2020-02-10

Lenalidomide in Chronic Lymphocytic Leukemia (CLL) Patients With Residual Disease

33 enrolled 8 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00602836 2020-01-27

Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

45 enrolled 13 charts

Leukemia, Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00899431 2020-01-27

Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)

39 enrolled 10 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02538965 2020-01-07

A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia

Other hematologic neoplasm

17 enrolled 21 charts

Leukemia, Leukemia, Myeloid, Recurrence, Leukemia, Myeloid, Acute

NCT00974233 2019-12-02

Study of Bendamustine/Rituxan Induction Chemotherapy With Revlimid Maintenance for Relapsed/Refractory CLL and SLL

34 enrolled 16 charts

Leukemia, Lymphocytic, Chronic, B-Cell

NCT01743859 2019-10-08

Azacitidine and Lenalidomide for Relapsed and Refractory Patients With Acute Myeloid Leukemia

Other hematologic neoplasm

37 enrolled 13 charts

Leukemia, Leukemia, Myeloid, Acute

NCT01358734 2019-06-25

A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) High-Dose Lenalidomide; (2) Lenalidomide + Azacitidine; or (3) Azacitidine in Subjects ≥ 65 Years With Newly-Diagnosed Acute Myeloid Leukemia

Other hematologic neoplasm

88 enrolled 17 charts

Leukemia, Myeloid, Acute

NCT01002755 2019-05-07

Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Classical hematologyLymphoidOther hematologic neoplasm

36 enrolled 7 charts

Lymphadenopathy, Agammaglobulinemia, Fatigue, Fever, Lymphocytosis, Paraproteinemias, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00860457 2018-11-21

Lenalidomide Following Fludarabine/Rituximab (FR) in Untreated Chronic Lymphocytic Leukemia (CLL)

22 enrolled 6 charts

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00963105 2018-10-31

Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

104 enrolled 18 charts

Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01924169 2018-09-20

Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)

3 enrolled 7 charts

Agammaglobulinemia, Hematologic Diseases, Influenza, Human, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00535873 2018-08-21

Lenalidomide as Initial Treatment of Patients With Chronic Lymphocytic Leukemia (CLL) Age 65 and Older

61 enrolled 5 charts

Leukemia, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01724177 2018-05-29

A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma

26 enrolled 15 charts

Leukemia-Lymphoma, Adult T-Cell

NCT02371590 2018-02-23

Lenalidomide and Obinutuzumab for Previously Untreated CLL

Phase 2 Withdrawn

Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT00742560 2018-01-10

A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma

Other hematologic neoplasmPlasma cell

101 enrolled 20 charts

Multiple Myeloma, Hematologic Neoplasms

NCT01442714 2018-01-03

Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS

MyeloidOther hematologic neoplasm

33 enrolled 11 charts

Leukemia, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01116193 2017-09-14

RV-405 LAL

10 enrolled

Leukemia, Lymphoid, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01419795 2017-07-27

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant